Watertown, MA, United States of America

Paul M Scola

This inventor holds 2 USPTO granted patents. Top assignee: Harvard College. Active years: 1994-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul M Scola. Retrieved from https://idiyas.com/inventor/paul-m-scola

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 121(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Paul M Scola

Introduction

Paul M Scola is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of novel chemical compounds. With a total of 2 patents, Scola's work has implications for the development of important therapeutic agents.

Latest Patents

Scola's latest patents focus on halichondrins and related compounds. These patents describe novel chemical compounds that can be used to synthesize halichondrin B and norhalichondrin B, along with their related derivatives. The total synthesis of halichondrin B and norhalichondrin B is also disclosed in these patents. The synthesis of these compounds is crucial for advancing research in medicinal chemistry.

Career Highlights

Paul M Scola is affiliated with Harvard College, where he continues to engage in innovative research. His work has garnered attention for its potential applications in drug development and synthesis. Scola's contributions to the field have established him as a respected figure among his peers.

Collaborations

Scola has collaborated with esteemed colleagues such as Yoshito Kishi and Francis Gerard Fang. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Paul M Scola's innovative work in the synthesis of halichondrins showcases his dedication to advancing the field of chemistry. His patents reflect a commitment to developing novel compounds that may lead to significant medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…